Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-02

FDA Approved: ADAPALENE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for adapalene from Alembic Pharmaceuticals, confirming approval of a generic adapalene product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)